|
|
Clinical Medical Science: Drug Design and Synthesis |
|
| 0001 | Drug Design |
| 0002 | Structural synthesis of small molecule
drug candidates
|
| 0003 | Synthesis of Potential Drugs for Thromboembolic
Heart Diseases
|
| 0004 | The design, synthesis, and evaluation of novel drug delivery systems
|
| 0005 | Design, synthesis, and biological evaluation ... |
| 0006 | Design, synthesis and structure
of peptides and proteins |
| 0007 | Design Synthesis and Biological Evaluation of New 8 Heterocyclic Xanthine Derivatives As Highly Potent and Selective Human A2B pdf |
| 0008 | Pharmaceutical Microbiology |
| 0009 | Strategies for Organic Drug Synthesis and Design |
| 0010 | Endogenous histamine inhibits the development of morphine-induced
conditioned place preference1 |
| 0011 | Neuroprotection of selenite against ischemic brain injury through negatively
regulating early activation of ASK1/JNK cascade via activation of
PI3K/AKT pathway1 |
| 0012 | Neuroprotection of selenite against ischemic brain injury through negatively
regulating early activation of ASK1/JNK cascade via activation of
PI3K/AKT pathway
|
| 0013 |
Nitric oxide modulates hypoxic pulmonary smooth muscle cell proliferation
and apoptosis by regulating carbon monoxide pathway1 |
| 0014 | Development of a homogeneous calcium mobilization assay for high
throughput screening of mas-related gene receptor agonists1
|
| 0015 | Design, synthesis, antitumor evaluations and molecular modeling
studies of novel 3,5-substituted indolin-2-one derivatives
|
| 0016 | Design and synthesis of new drugs and materials |
| 0017 | Design, synthesis, and evaluation of potent bryostatin analogs that modulate PKC translocation selectivity |
| 0018 | The Virtual Laboratory:
a toolset to enable distributed
molecular modelling for drug
design on the World-Wide Grid
|
| 0019 | Design, synthesis and biological evaluation of taxane-based anticancer agents. II. Targeting FtsZ for antituberculosis drug discovery |
| 0020 | Rational approaches to natural-product-based drug design |
| 0021 | Patent application title: Method of Drug Design
|
| 0022 | Identification of Inhibitors of the Tyrosine Kinase c-Met by Structure-Based Virtual Screening
|
| 0023 | Inhibitors of signal transduction protein kinases as targets for cancer therapy
|
| 0024 | Structural Insights for Design of Potent Spleen Tyrosine Kinase Inhibitors from Crystallographic
Analysis of Three Inhibitor Complexes
|
| 0025 | Lessons learned from the development of an
Abl tyrosine kinase inhibitor for
chronic myelogenous leukemia
|
| 0026 | 3D-QSAR of Protein Tyrosine Phosphatase 1B Inhibitors by
Genetic Function Approximation
|
| 0027 | Molecular mechanisms of acquired resistance to tyrosine kinase targeted therapy
|
| 0028 | Drugs from the deep: marine natural
products as drug candidates
|
| 0029 | Inhibitors of growth factor signalling
|
| 0030 | Purification and Identification of Protein-Tyrosine Kinase-binding Proteins Using Synthetic Phosphopeptides as Affinity Reagents *
|
|
The Horn of Africa Research and Knowledge Exchange Platform © 2010-2016 www.harep.org rkidane@talk21.com Contact: Please click Here to send your feedback |
.
Clinical Pharmacology Therapeutics
Pharmaceutical& Organic Chemistry
Cardiovascular/Pulmonary Pharmacology
Drugs acting on the digestive system
Drugs acting on the reproductive organs